Showing 1 - 3 results of 3 for search 'Mariela Sivina', query time: 0.02s Refine Results
  1. 1
    P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL

    P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL by Jan Burger, Ekaterina Kim, Mariela Sivina, Ghayas Issa, Philip Thompson, William G. Wierda, Alessandra Ferrajoli

    Published 2023-08-01
    Get full text
    Article
  2. 2
    The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells.

    The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells. by Stefania Fiorcari, Wells S Brown, Bradley W McIntyre, Zeev Estrov, Rossana Maffei, Susan O'Brien, Mariela Sivina, Julia Hoellenriegel, William G Wierda, Michael J Keating, Wei Ding, Neil E Kay, Brian J Lannutti, Roberto Marasca, Jan A Burger

    Published 2013-01-01
    Get full text
    Article
  3. 3
    Dynamic changes of the normal B lymphocyte repertoire in CLL in response to ibrutinib or FCR chemo-immunotherapy

    Dynamic changes of the normal B lymphocyte repertoire in CLL in response to ibrutinib or FCR chemo-immunotherapy by Simon Schliffke, Mariela Sivina, Ekaterina Kim, Lisa von Wenserski, Benjamin Thiele, Nuray Akyüz, Clemens Falker-Gieske, Donjete Statovci, Anna Oberle, Toni Thenhausen, Artus Krohn-Grimberghe, Carsten Bokemeyer, Nitin Jain, Zeev Estrov, Alessandra Ferrajoli, William Wierda, Michael Keating, Jan A. Burger, Mascha Binder

    Published 2018-04-01
    Get full text
    Article

Search Tools: